Genuity Capital Markets
http://www.genuitycm.com/Genuity Capital Markets is a financial services firm providing investment banking, institutional sales and trading, and equity research to its corporate clients. The firm uses a simple Buy, Hold and Sell rating system in its research analysis.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates a 'Buy' on Foot Locker (FL); Athletic Channel Checks Strong
-
Canaccord Genuity Maintains a 'Buy' on Oracle (ORCL); Expectations from OpenWorld Analyst Day
-
Canaccord Genuity Reiterates a 'Buy' on Apple (AAPL); Launches iPhone 4S
-
Canaccord Genuity Reiterates a 'Buy' on Analog Devices (ADI); CQ4 Looks Like Bottom, Dividend Could Increase
-
Canaccord Genuity Maintains a 'Hold' on Talisman Energy (TLM); Headline Risk Continues
-
Notable Analyst Rating Changes 10/04: (AMR) (SODA) (PLCM) Upgraded; (MDR) (GMR) (GTIV) Downgraded
-
Canaccord Genuity on Sustainability & CleanTech -- Energy & Power Technologies: Metering Europe Day 1
-
Canaccord Genuity Maintains a 'Buy' on Complete Production Services (CPX); Rebound Candidate If No Recession
-
UPDATE - Canaccord Genuity Upgraded Forest Oil (FST) to Buy; Spin-off Overhang Pruned, Healthy Assets Remain
-
Canaccord Genuity Upgrades Forest Oil (FST) to Buy
-
Canaccord Genuity Maintains a 'Buy' on Watson Pharmaceuticals (WPI); PROCHIEVE Survey Supports Above-consensus View
-
Canaccord Genuity Reiterates a 'Buy' on TranS1 Inc (TSON); Follow-on Offering Extends Runway
-
Canaccord Genuity Reiterates a 'Buy' on Heartware Intl (HTWR); Positive HVAD Data at EACTS
-
Canaccord Genuity maintains a 'Hold' on Rubicon Technology (RBCN); Lowering PT Post Asia LED Tour
-
Canaccord Genuity Reiterates a 'Buy' on Qualcomm (QCOM); Checks Indicate Ramping China 3G Sales, Share Gains with Tier-1 OEMs
-
Canaccord Genuity Reiterates a 'Buy' on NetQin Mobile (NQ); Upbeat Management Meeting in Beijing, New iOS Product Demo
-
Canaccord Genuity Reiterates a 'Buy' on Cogo Group (COGO); Management Meeting in Shenzhen, Focus on L-T Growth Plans
-
Canaccord Genuity Reiterates a 'Buy' on Unit Corp. (UNT); Management Meeting Takeaways
-
Canaccord Genuity on Sustainability & CleanTech -- Energy & Power Technologies: A Glimpse Ahead At Metering Europe
-
Canaccord Genuity reiterates a 'Buy' on Raptor Pharmaceuticals (RPTP); Positive RP103 Pivotal Data
-
Canaccord Genuity Reiterates a 'Buy' on Aegerion Pharmaceuticals (AEGR); Positive EMA Meetings: Q1/12 ffiling of Lomitapide NDA and MAA Planned
-
Canaccord Genuity Reiterates a 'Buy' on Horsehead (ZINC); Quick Hedging Program Refresher
-
Canaccord Genuity Maintains a 'Hold' on Insituform (INSU); Visibility is The Villain (Again);
-
Canaccord Genuity Starts American Standard Energy (ASEN) at Buy
-
Canaccord Genuity Maintains a 'Hold' on Nokia (NOK); Announces Next Phase of Restructuring/Cost Reduction Programs
-
Canaccord Genuity Reiterates a 'Buy' on Quidel Corp (QDEL); Announces Buy-Out of Royalty Rate
-
Canaccord Genuity Reiterates a 'Buy' on InterMune (ITMN); UK IPF Doc Call: Gradual Switch to Esbriet
-
Canaccord Genuity Maintains a 'Buy' on Heartware Intl (HTWR); HVAD Data Update This Weekend Could be Positive Catalyst
-
Canaccord Genuity Maintains a 'Buy/Best Idea' on NCI Building Systems (NCS); Pending Legislation Could Benefit
-
Canaccord Genuity Reiterates a 'Buy' on AMD (AMD); Healthy Prospects for Llano Despite Supply Disruption
-
Notable Analyst Rating Changes 09/28: (BMRN) (LEAP) (MAS) Upgraded; (BZ) (BPO) (KMB) Downgraded
-
Canaccord Genuity on Life Sciences/Specialty Pharmaceuticals: Bottom-Up Approach to Volatile Sector - Initiating Coverage on Seven Stocks
-
Canaccord Genuity Reiterates a 'Buy' on Swift Energy (SFY); Strong Operational Results to Address Valuation Disconnect
-
Canaccord Genuity Reiterates a 'Buy' on Standard Microsystems (SMSC); Auto Momentum
-
Canaccord Genuity Maintains a 'Buy' on Velti (VELT); Addressing Primary Investor Concerns
-
Canaccord Genuity Maintains a 'Hold' on Exelixis (EXEL); Cautious Ahead of Cabo P3 MTC Data
-
Canaccord Genuity reiterates a 'Buy' on EnteroMedics (ETRM); Completes follow-on Offering, Bolsters Cash Position
-
Canaccord Genuity Starts Warner Chilcott (WCRX) at Buy; Compelling Deep Value Story
-
Canaccord Genuity Starts Watson Pharmaceuticals (WPI) at Buy; Solid Pipeline with Near-term Catalysts
-
Canaccord Genuity Starts Teva Pharma (TEVA) at Buy; Accumulate Shares Ahead of 2012 Inflection Point
-
Canaccord Genuity Starts Perrigo Co. (PRGO) at Hold; Solid Defensive Play in a Tough Tape, but Reflected in Stock
-
Canaccord Genuity Starts Mylan (MYL) at Hold; Near-term Earnings Risk Tempers Otherwise Upbeat View
-
Canaccord Genuity Starts Medicis (MRX) at Buy; Top Small-Cap Idea -- SOTP the Key
-
Canaccord Genuity Starts Impax Laboratories (IPXL) at Hold; Near-term Headwinds Offset Deep Discount
-
Canaccord Genuity on Sustainability & CleanTech -- Recycling: Growling Bear
-
Canaccord Genuity on Energy - Oilfield Services: Recession Stress Test, Reducing Targets
-
Canaccord Genuity Reiterates a 'Buy' on Avanir Pharmaceuticals (AVNR); Nuedexta August '11 RX Update: Positive Trends Continue
-
Canaccord Genuity Maintains a 'Hold' on Universal Display (PANL); No Changes Post Korea Meetings
-
Canaccord Genuity Reiterates a 'Buy' on Integrated Device Technology (IDTI); Lowered Outlook In Step With Broad Semi Weakness
-
TranS1 Inc. (TSON) Closes 6.2 Million Share Public Offering
